Evidence map›Paper›PMID 32150849›Full record

ReviewBiomolecules2020

Involvement of Metabolic Lipid Mediators in the Regulation of Apoptosis.

Piotr Wójcik, Neven Žarković, Agnieszka Gęgotek, Elżbieta Skrzydlewska

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Phytocannabinoids in the Pharmacotherapy of Psoriasis.Molecules (Basel, Switzerland) · 2023
    Review
  17. Review
  18. Impact of ROS-Dependent Lipid Metabolism on Psoriasis Pathophysiology.International journal of molecular sciences · 2022
    Review
  19. Article
  20. Lipid Metabolism and Cancer.Life (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Piotr WójcikDepartment of Analytical Chemistry, Medical University of Bialystok, 15-089 Białystok, Poland.
Neven ŽarkovićLabOS, Rudjer Boskovic Institute, Laboratory for Oxidative Stress, Bijenicka 54, HR-1000 Zagreb, Croatia.
Agnieszka GęgotekDepartment of Analytical Chemistry, Medical University of Bialystok, 15-089 Białystok, Poland.
Elżbieta SkrzydlewskaDepartment of Analytical Chemistry, Medical University of Bialystok, 15-089 Białystok, Poland.
Medical University of Białystok · PLRuđer Bošković Institute · HR

Funding

Narodowa Agencja Wymiany Akademickiej PPI/APM/2018/00015/U/001
6 · The paper itself

Abstract

Apoptosis is the physiological mechanism of cell death and can be modulated by endogenous and exogenous factors, including stress and metabolic alterations. Reactive oxygen species (ROS), as well as ROS-dependent lipid peroxidation products (including isoprostanes and reactive aldehydes including 4-hydroxynonenal) are proapoptotic factors. These mediators can activate apoptosis via mitochondrial-, receptor-, or ER stress-dependent pathways. Phospholipid metabolism is also an essential regulator of apoptosis, producing the proapoptotic prostaglandins of the PGD and PGJ series, as well as the antiapoptotic prostaglandins of the PGE series, but also 12-HETE and 20-HETE. The effect of endocannabinoids and phytocannabinoids on apoptosis depends on cell type-specific differences. Cells where cannabinoid receptor type 1 (CB1) is the dominant cannabinoid receptor, as well as cells with high cyclooxygenase (COX) activity, undergo apoptosis after the administration of cannabinoids. In contrast, in cells where CB2 receptors dominate, and cells with low COX activity, cannabinoids act in a cytoprotective manner. Therefore, cell type-specific differences in the pro- and antiapoptotic effects of lipids and their (oxidative) products might reveal new options for differential bioanalysis between normal, functional, and degenerating or malignant cells, and better integrative biomedical treatments of major stress-associated diseases.

Indexed as

ApoptosisLipid MetabolismLipid PeroxidationOxidative StressAnimalsArachidonic AcidsHumansProstaglandin-Endoperoxide SynthasesReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2Arachidonic AcidsCNR2 protein, humanProstaglandin-Endoperoxide SynthasesReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2apoptosisendocannabinoidslipid mediatorsoxidative stressphospholipidsROS

Identifiers

PMID32150849
PMCPMC7175142
OpenAlexW3009497204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.